Publication | Closed Access

The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial

Bone DiseaseBreast OncologyMedicinePathologyBreast CancerCancer TreatmentOncologyRadiation OncologyOsteoporosisOrthopaedic SurgeryEstablished Bone Metastases